ASM Results

Page 1 of 1
8 September 2020

Results of 2020 Annual Shareholder Meeting

At AFT Pharmaceuticals Limited’s (NZX: AFT / ASX: AFP) annual shareholder meeting held virtually
today, shareholders were asked to vote on two resolutions, both of which were supported by the
Board.

As required by NZX Listing Rule 6.1, all voting was conducted by a poll.

The resolutions passed by shareholders were:

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for
the 2021 financial year.

2. That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

Detail of the total number of votes cast in person or by a proxy holder are:

Resolution For Against Abstain

1. That the directors are authorised to fix the
fees and expenses of Deloitte as auditor
for the 2021 financial year.

87,540,520
99.99%

11,972
0.01%


2,000



2. That Ms Marree Atkinson be re-elected as
a director of AFT Pharmaceuticals
Limited.

87,552,227
100.00%
1,145
0.00%
120


Authority for this announcement
Name of person authorised to make this
announcement
Malcolm Tubby, Chief Financial Officer
Contact person for this announcement Malcolm Tubby
Contact phone number +64 9 488 0232
Contact email address Investor.relations@aftpharm.com
Date of release through MAP 8 September 2020